About the Authors

Flore Decuypere

flore.decuypere@quintilesims.com (FD); jsermon@its.jnj.com (JS); pgeerts@its.jnj.com (PG); tdenee@its.jnj.com (TRD); cdevos4@its.jnj.com (CDV); bmalfait@its.jnj.com (BM); mark.lamotte@quintilesims.com (ML)

Affiliation Commercial Services, QuintilesIMS, Zaventem, Belgium

Jan Sermon

flore.decuypere@quintilesims.com (FD); jsermon@its.jnj.com (JS); pgeerts@its.jnj.com (PG); tdenee@its.jnj.com (TRD); cdevos4@its.jnj.com (CDV); bmalfait@its.jnj.com (BM); mark.lamotte@quintilesims.com (ML)

Affiliation Health Economics, Market Access, Reimbursement, Janssen-Cilag NV, Beerse, Belgium

Paul Geerts

flore.decuypere@quintilesims.com (FD); jsermon@its.jnj.com (JS); pgeerts@its.jnj.com (PG); tdenee@its.jnj.com (TRD); cdevos4@its.jnj.com (CDV); bmalfait@its.jnj.com (BM); mark.lamotte@quintilesims.com (ML)

Affiliation Medical Affairs, Janssen-Cilag NV, Beerse, Belgium

Tom R. Denee

flore.decuypere@quintilesims.com (FD); jsermon@its.jnj.com (JS); pgeerts@its.jnj.com (PG); tdenee@its.jnj.com (TRD); cdevos4@its.jnj.com (CDV); bmalfait@its.jnj.com (BM); mark.lamotte@quintilesims.com (ML)

Affiliation Health Economics, Market Access, Reimbursement, Janssen-Cilag BV, Tilburg, Netherlands

Cedric De Vos

flore.decuypere@quintilesims.com (FD); jsermon@its.jnj.com (JS); pgeerts@its.jnj.com (PG); tdenee@its.jnj.com (TRD); cdevos4@its.jnj.com (CDV); bmalfait@its.jnj.com (BM); mark.lamotte@quintilesims.com (ML)

Affiliation Health Economics, Market Access, Reimbursement, Janssen-Cilag NV, Beerse, Belgium

Bart Malfait

flore.decuypere@quintilesims.com (FD); jsermon@its.jnj.com (JS); pgeerts@its.jnj.com (PG); tdenee@its.jnj.com (TRD); cdevos4@its.jnj.com (CDV); bmalfait@its.jnj.com (BM); mark.lamotte@quintilesims.com (ML)

Affiliation Health Economics, Market Access, Reimbursement, Janssen-Cilag NV, Beerse, Belgium

Mark Lamotte

flore.decuypere@quintilesims.com (FD); jsermon@its.jnj.com (JS); pgeerts@its.jnj.com (PG); tdenee@its.jnj.com (TRD); cdevos4@its.jnj.com (CDV); bmalfait@its.jnj.com (BM); mark.lamotte@quintilesims.com (ML)

Affiliation Real-World Evidence Solutions, QuintilesIMS, Zaventem, Belgium

Cornelis L. Mulder

Affiliation Department of Psychiatry, Erasmus MC, Rotterdam, Netherlands

Competing Interests

We have the following interests. This study was funded by Janssen-Cilag. QuintilesIMS, the employer of F. Decuypere and M. Lamotte, received consulting fees for the performance of the study and the writing of the manuscript. Janssen-Cilag participated in collaboration with QuintilesIMS to design the study; Janssen-Cilag had no role in the collection and analysis of the data; Janssen-Cilag participated in collaboration with QuintilesIMS in the interpretation of the data, in the writing of the report and in the decision to submit the paper for publication. J. Sermon, P. Geerts, T.R. Denee, C. de Vos and B. Malfait are full-time employees of Janssen-Cilag. F. Decuypere and M. Lamotte are full-time employees of QuintilesIMS and have consulted for Janssen-Cilag. C.L. Mulder declares that the department has received an educational grant for the Care4Today program from Healthy Solutions, a JnJ subsidiary. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.

Author Contributions

Conceptualization: FD JS PG TRD CDV BM ML CLM. Data curation: FD. Formal analysis: FD. Funding acquisition: JS. Investigation: FD. Methodology: FD JS. Project administration: FD. Resources: FD. Software: FD. Supervision: FD. Visualization: FD. Writing – original draft: FD. Writing – review & editing: FD JS PG TRD CDV BM ML CLM.